Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients
Public ClinicalTrials.gov record NCT00103662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Comparative Trial of AMD3100 Plus G-CSF Versus G-CSF Plus Placebo to Mobilize and Collect ≥ 6*10^6 CD34+ Cells/kg in Multiple Myeloma Patients for Autologous Transplantation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether the combination of AMD3100 (plerixafor) and granulocyte colony-stimulating factor (G-CSF, generic name of filgrastim) is better than G-CSF alone to mobilize and collect the optimal number of stem cells in multiple myeloma patients for autologous transplantation.
Study identification
- NCT ID
- NCT00103662
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 302 participants
Conditions and interventions
Conditions
Interventions
- Granulocyte colony-stimulating factor plus plerixafor Drug
- Granulocyte colony-stimulating factor plus placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 78 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2005 (Type not available)
- Primary completion
- Oct 2006 (Actual)
- Completion
- Jan 2008 (Actual)
- Last update posted
- Mar 13, 2014
2005 – 2008
United States locations
- U.S. sites
- 37
- U.S. states
- 22
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| City of Hope Samaritan Bone Marrow Transplant Program | Phoenix | Arizona | 85006 | — |
| Myeloma Institute for Research and Therapy, University of Arkansas for Medical Sciences | Little Rock | Arkansas | 72205 | — |
| City of Hope National Medical Center | Duarte | California | 91010 | — |
| Cedars-Sinai | Los Angeles | California | 90048 | — |
| University of California | Los Angeles | California | 90095 | — |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| University of Florida | Gainesville | Florida | 32611 | — |
| H. Lee Moffitt Cancer Center and Research Institute | Tampa | Florida | 33612 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Loyola University Medical Center | Maywood | Illinois | 60153 | — |
| Indiana Blood and Marrow Transplantation Center | Beech Grove | Indiana | 46107 | — |
| University of Iowa Hosptials and Clinics | Iowa City | Iowa | 52242 | — |
| Fairview-University Medical Center, University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Kansas City Cancer Center | Kansas City | Missouri | 64111 | — |
| Washington University School of Medicine, Division of Bone Marrow Transplantation and Leukemia | St Louis | Missouri | 63110 | — |
| The Cancer Center at Hackensack University Medical Center | Hackensack | New Jersey | 07601 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| St. Vincent's Comprehensive Cancer Center | New York | New York | 10011 | — |
| New York Hospital | New York | New York | 10032 | — |
| Memorial Sloan Kettering | New York | New York | 10065 | — |
| University of Rochester Medical Center | Rochester | New York | 14642 | — |
| Duke University Medical Center | Durham | North Carolina | 27705 | — |
| Case Western Reserve University | Cleveland | Ohio | 44106 | — |
| Cleveland Clinic Foundation | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Wilford Hall Medical Center | Lackland Air Force Base | Texas | 78236 | — |
| Texas Transplant Institute | San Antonio | Texas | 78229 | — |
| University of Texas Health Science Center | San Antonio | Texas | 78229 | — |
| Utah Blood and Marrow Transplant Program, University of Utah | Salt Lake City | Utah | 84132 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00103662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 13, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00103662 live on ClinicalTrials.gov.